199 related articles for article (PubMed ID: 22345291)
1. A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein.
Tiong CT; Chen C; Zhang SJ; Li J; Soshilov A; Denison MS; Lee LS; Tam VH; Wong SP; Xu HE; Yong EL
Carcinogenesis; 2012 May; 33(5):1089-97. PubMed ID: 22345291
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
Wihlén B; Ahmed S; Inzunza J; Matthews J
Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.
Brinkman AM; Wu J; Ersland K; Xu W
BMC Cancer; 2014 May; 14():344. PubMed ID: 24885022
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells.
Macpherson L; Matthews J
Cancer Lett; 2010 Dec; 299(2):119-29. PubMed ID: 20846786
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor-α and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells.
Gong P; Madak-Erdogan Z; Flaws JA; Shapiro DJ; Katzenellenbogen JA; Katzenellenbogen BS
Mol Cell Endocrinol; 2016 Dec; 437():190-200. PubMed ID: 27543265
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
[TBL] [Abstract][Full Text] [Related]
7. The Aryl Hydrocarbon Receptor Ligand 6-Formylindolo(3,2-b)carbazole Promotes Estrogen Receptor Alpha and c-Fos Protein Degradation and Inhibits MCF-7 Cell Proliferation and Migration.
Cano-Sánchez J; Murillo-González FE; de Jesús-Aguilar J; Cabañas-Cortés MA; Tirado-Garibay AC; Elizondo G
Pharmacology; 2023; 108(2):157-165. PubMed ID: 36657432
[TBL] [Abstract][Full Text] [Related]
8. Dioxin and estrogen signaling in lung adenocarcinoma cells with different aryl hydrocarbon receptor/estrogen receptor α phenotypes.
Kuo LC; Cheng LC; Lin CJ; Li LA
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1064-73. PubMed ID: 23855798
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
Matthews J; Wihlén B; Thomsen J; Gustafsson JA
Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
[TBL] [Abstract][Full Text] [Related]
10. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
Spink BC; Fasco MJ; Gierthy JF; Spink DC
J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
[TBL] [Abstract][Full Text] [Related]
11. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line.
García MA; Peña D; Alvarez L; Cocca C; Pontillo C; Bergoc R; de Pisarev DK; Randi A
Toxicol Lett; 2010 Feb; 192(2):195-205. PubMed ID: 19879930
[TBL] [Abstract][Full Text] [Related]
12. Co-planar 3,3',4,4',5-pentachlorinated biphenyl and non-co-planar 2,2',4,6,6'-pentachlorinated biphenyl differentially induce recruitment of oestrogen receptor alpha to aryl hydrocarbon receptor target genes.
Matthews J; Wihlén B; Heldring N; MacPherson L; Helguero L; Treuter E; Haldosén LA; Gustafsson JA
Biochem J; 2007 Sep; 406(2):343-53. PubMed ID: 17511620
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
Madak-Erdogan Z; Katzenellenbogen BS
Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S
Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of estrogen receptor α by vorinostat sensitizes mesenchymal-like triple-negative breast cancer to aminoflavone, a ligand of the aryl hydrocarbon receptor.
Stark K; Burger A; Wu J; Shelton P; Polin L; Li J
PLoS One; 2013; 8(9):e74525. PubMed ID: 24058584
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
[TBL] [Abstract][Full Text] [Related]
17. The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.
Wormke M; Stoner M; Saville B; Walker K; Abdelrahim M; Burghardt R; Safe S
Mol Cell Biol; 2003 Mar; 23(6):1843-55. PubMed ID: 12612060
[TBL] [Abstract][Full Text] [Related]
18. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
[TBL] [Abstract][Full Text] [Related]
19. Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models.
Go RE; Hwang KA; Kim CW; Byun YS; Nam KH; Choi KC
Environ Toxicol; 2017 Oct; 32(10):2225-2233. PubMed ID: 28618207
[TBL] [Abstract][Full Text] [Related]
20. The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.
Lo R; Matthews J
Toxicol Appl Pharmacol; 2013 Jul; 270(2):139-48. PubMed ID: 23583297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
